Incyte (INCY) Operating Income Growth (3y) (2013 - 2026)
Incyte (INCY) Operating Income Growth (3y) (2013 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Op. Inc Growth (3y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 65,538.84 Bn | 65,538.56 Bn | - | 16.96% |
| 2 | Nanobiotix | 1,912.79 Bn | 1,912.72 Bn | - | - |
| 3 | Akari Therapeutics | 1,009.43 Bn | 1,009.43 Bn | - | - |
| 4 | BeOne Medicines | 469.46 Bn | 464.67 Bn | 1.35 Bn | 38.78% |
| 5 | Vertex Pharmaceuticals | 122.69 Bn | 115.45 Bn | 2.59 Bn | 13.47% |
| 6 | Regeneron Pharmaceuticals | 70.41 Bn | 61.65 Bn | 3.31 Bn | -12.10% |
| 7 | Belite Bio | 62.84 Bn | 62.84 Bn | - | - |
| 8 | Argenx Se | 56.10 Bn | 50.91 Bn | 1.41 Bn | 69.02% |
| 9 | Alnylam Pharmaceuticals | 37.48 Bn | 34.47 Bn | 959.66 Mn | 55.96% |
| 10 | Incyte | 23.74 Bn | 19.73 Bn | 1.17 Bn | 129.93% |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 129.93% |
| Dec 31, 2025 | 68.59% |
| Sep 30, 2025 | 47.44% |
| Jun 30, 2025 | 27.74% |
| Mar 31, 2025 | 20.75% |
| Dec 31, 2024 | 39.64% |
| Sep 30, 2024 | -14.70% |
| Jun 30, 2024 | -75.39% |
| Mar 31, 2024 | -2.38% |
| Dec 31, 2023 | 4.47% |
| Sep 30, 2023 | 242.88% |
| Jun 30, 2023 | -5.66% |
| Mar 31, 2023 | 26.77% |
| Dec 31, 2022 | -9.64% |
| Sep 30, 2022 | 1.00% |
| Jun 30, 2022 | 37.16% |
| Mar 31, 2022 | 16.31% |
| Dec 31, 2021 | 10.54% |
| Sep 30, 2021 | 96.31% |
| Jun 30, 2021 | 19.16% |